Improving bone mineral density screening in patients with inflammatory bowel disease: a quality improvement report

The prevalence of osteopenia and osteoporosis in patients with inflammatory bowel disease (IBD) is estimated between 17% and 41%, partly due to repeat courses of glucocorticoids which enhance the risk for bone disease. Multiple gastroenterological and endocrine societies have established guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah-Khan, Sardar Momin, Cumberledge, Jeremy, Shah-Khan, Sardar Musa, Gannon, Kelley, Kupec, Justin T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Quality Improvement Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711427/
https://www.ncbi.nlm.nih.gov/pubmed/31523738
http://dx.doi.org/10.1136/bmjoq-2019-000624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711427/
https://www.ncbi.nlm.nih.gov/pubmed/31523738
http://dx.doi.org/10.1136/bmjoq-2019-000624

Ejemplares similares